Home›Companies›Biotech & Pharma›Afaxys

Afaxys, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 14, 2025·Suggest an edit

About Afaxys

Afaxys is a private company based in Charleston, South Carolina. It has reported $0 raised in four offerings on Form D since October 2010. Its chief executive is Ronda Dean.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetJul 14, 2025$0of $5.0M target0—EquityRule 506(b)Form D ↗
Jun 27, 2023Jun 28, 2023$0of $46.8M target0—EquityRule 506(b)Form D ↗
Not yetJan 4, 2023$0of $50.0M target0—EquityRule 506(b)Form D ↗
Not yetOct 21, 2010$0of $6.6M target0—Equity06Form D ↗
Total, four offerings$0

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Afaxys's Form D filed Jul 14, 2025.

VR
RM
Rod Markin
Director
JN
SC
Stacy Cross
Director
RD
Ronda Dean
Chief Executive Officer and director
SS
Sarah Stoesz
Director

Earlier filings also listed Kirk Calhoun (director, last listed Jun 2023), James Nash (director, last listed Jun 2023), Elizabeth Davila (director, last listed Jun 2023), Bruce Williams (director, last listed Jun 2023), Susan Overly (executive officer, last listed Oct 2010), Linda Williams (director, last listed Oct 2010), Harold Oberkfell (director, last listed Oct 2010) and Christine Charbonneau (director, last listed Oct 2010).

Sources

  1. SECAfaxys, Inc. filing history